Aspirin, clopidogrel, or both for secondary prevention of coronary disease

N Engl J Med. 2003 Feb 6;348(6):560-3; author reply 560-3. doi: 10.1056/NEJM200302063480616.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Aspirin / economics*
  • Aspirin / therapeutic use
  • Clopidogrel
  • Coronary Disease / drug therapy*
  • Cost-Benefit Analysis
  • Drug Costs
  • Drug Industry / economics*
  • Fees, Pharmaceutical
  • Humans
  • Platelet Aggregation Inhibitors / economics*
  • Platelet Aggregation Inhibitors / therapeutic use
  • Ticlopidine / analogs & derivatives*
  • Ticlopidine / economics*
  • Ticlopidine / therapeutic use

Substances

  • Platelet Aggregation Inhibitors
  • Clopidogrel
  • Ticlopidine
  • Aspirin